Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. G.A. Huls

Publicaties

Consolidation With Second High Dose Therapy and Autologous Stem Cell Transplantation Is Associated With Improved Overall Survival in Patients With Multiple Myeloma in First Relapse

Donor lymphocyte infusions after HLA-identical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in acute myeloid leukemia patients

Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy

High expression of signal regulatory protein beta 2 marks a favourable prognostic AML subgroup and associates with increased sensitivity to phagocytosis

Increased Clonal Hematopoiesis in Long-term Survivors of Pediatric Hematopoietic Cell Transplantation

K12-ligand-based CAR T cell therapy for CD7-positive T cell malignancies

Long-term survival can be achieved in a significant fraction of older patients with core-binding factor acute myeloid leukemia treated with intensive chemotherapy

Midostaurin added to 10-day decitabine, for patients unfit for intensive chemotherapy with AML and higher risk MDS, irrespective of FLT3 mutational status, does not improve outcome

Patients With Relapsed Large B-Cell Lymphoma After 12 Months Have a Similarly Poor Prognosis to Those Relapsing Within 12 Months

The association between hospital volume and overall survival in adult AML patients treated with intensive chemotherapy

Pers/media

Professor Dr. Gerwin Huls te gast bij Nutsdepartement Vlagtwedde

Professor Dr. Gerwin Huls te gast bij Nutsdepartement Vlagtwedde

Nationaal Groeifonds investeert in UMCG-studies om ontwikkeling kankermedicijnen te versnellen